The current state of resistance of aerobic and facultative anaerobic clinical bacteria isolates;Resistenzsituation aerober und fakultativ anaerober klinischer bakterienisolate

Chemotherapie Journal

Volumn 10, Issue 1, 2001, Pages 1-19

  Stock, I ^a   Machka, K ^a   Wiedemann, B ^a   Bitter Suermann, D ^a   Brade, V ^a   Dickgiesser N ^a   Focht, J ^a   Geis, L ^a   Goebel, U ^a   Grimm, H ^a   Hartinger, A ^a   Hof, H ^a   Hopken M E ^a   Just, M ^a   Krupe H ^a   Lehn, N ^a   Lobel D ^a   Lutticken R ^a   Mauch, H ^a   Panzig, B ^a   Pelz, K ^a   Peters, G ^a   Rodloff, A ^a   Ruckdeschel, G ^a   Schassan, H H ^a   Schmidt, H ^a   Seifert, H ^a   Shah, P ^a   Straube, E ^a   Warweg, U ^a   Werner, H ^a   more..

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; ERYTHROMYCIN; FLUCLOXACILLIN; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; PSEUDOMONIC ACID; TOBRAMYCIN; VANCOMYCIN;

AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATION;

EID: 0035134204     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Antimicrobial resistance in Streptococcus pyogenes isolates in Berlin
2. Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus
3. Aus blut isolierte enterokokken (1989-1993): Evolution der antibiotika-empfindlichkeit
4. In vitro activity of several antimicrobial agents against 1003 isolates of Streptococcus pyogenes collected from Western Canada
5. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis
6. Antimicrobial susceptibility and ß-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988
7. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe
8. A multicentre collaborative study of the antimicrobial susceptibility of community-acquired, lower respiratory tract pathogens 1992-1993: The Alexander Project
9. In vitro efficacy of beta-lactam/beta-lactamase inhibitor combinations against bacteria involved in mixed infections
10. Susceptibility of Moraxella catarrhalis isolates to ß-lactam antibiotics in relation to ß-lactamase type
11. Antimicrobial susceptibility of 1422 Haemophilus influenzae isolates from respiratory tract infections in Spain. Results of a one-year (1996-1997) multicenter surveillance study
12. Epidemiology of quinolone resistance: Europe and North and South America
13. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States
14. Comparative activities of ciprofloxacin, clinafloxacin, gatifloxacin, gemifloxacin, levofloxacin, moxifloxacin, and trovafloxacin against epidemiologically defined Acinetobacter baumannii strains
15. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility
16. The second European collaborative study on the frequency of antimicrobial resistance in Haemophilus influenzae
17. Cloning and nucleotide sequence of the DANN gyrase gyrA gene from Serratia marcescens and characterization of mutations in gyrA of quinolone-resistant clinical isolates
18. Prävalenz der Antibiotikaresistenz bei klinisch wichtigen infektionserregern in mitteleuropa
19. Drug resistance among clinical isolates of frequently encountered bacterial species in Central Europe during 1975-1995
20. Resistenzsituation bei klinisch wichtigen infektionserregern gegenüber chemotherapeutika in mitteleuropa
21. Die epidemiologie der resistenz bei bakterien und ihre bedeutung für die wirksamkeit von chemotherapeutika
22. Vancomycin-resistant enterococci: The clinical effect of a common nosocomial pathogen
23. β-lactamases in laboratory and clinical resistance
24. Weitere bakterielle substanzen
25. In vitro activity of piperacillin/tazobactam versus other broad-spectrum antibiotics against nosocomial gram-negative pathogens isolated from burn patients
26. Life and times of the Enterococcus
27. Antibiotic resistance among recent clinical isolates of Haemophilus influenzae in Japanese children
28. Purulente infekte: Methicillin-resistente Staphylococcus aureus (MRSA) - Klinische implikationen
29. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital
30. Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: Trend analysis
31. Antimicrobial resistance and type distribution of Streptococcus pneumoniae in Germany, 1992-1994
32. β-lactam resistance in gram-negative bacteria.: Global trends and clinical impact
33. Characterisation of the chromosomal aac(6′)-Ic gene from Serratia marcescens
34. Qualitätssicherung und qualitätskontrollen in der antibiotika-empfindlichkeitsbestimmung von bakterien mit hilfe der mikrodilution
35. Characterisation of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides
36. Survey of susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates to 26 antimicrobial agents: A prospective US: Study
37. Antimicrobial resistance in respiratory tract pathogens: Results of an international surveillance study
38. Comparative susceptibility of clinical group A, B, C, F, and G betahaemolytic streptococcal isolates to 24 antimicrobial drugs
39. Enterococcus faecium: In vitro activity of antimicrobial drugs, singly and combined, with and without defibrinated human blood, against multiple-antibiotic-resistant strains
40. Activities of ß-lactams against Acinetobacter genospecies as determined by agar dilution and E-Test MIC methods
41. In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescens
42. Effect of inoculum size on the in-vitro susceptibility to β-lactam antibiotics of Moraxella catarrhalis with different β-lactamase types